Literature DB >> 1663769

Neuromuscular complications of HIV infection and its treatment.

D M Simpson, D E Wolfe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663769     DOI: 10.1097/00002030-199108000-00001

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

Review 1.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

2.  Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment.

Authors:  M E Cornford; H W Ho; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 3.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

4.  Impact of long-term treatment with neurotoxic dideoxynucleoside antiretrovirals: implications for clinical care in resource-limited settings.

Authors:  C F Hung; S A Gibson; S L Letendre; J T Lonergan; J A Marquie-Beck; F Vaida; R J Ellis
Journal:  HIV Med       Date:  2008-07-21       Impact factor: 3.180

5.  Neurophysiological assessment of peripheral nerve and spinal cord function in asymptomatic HIV-1 infection: results from the UCMSM/Medical Research Council neurology cohort.

Authors:  S Connolly; H Manji; R H McAllister; G B Griffin; C Loveday; C Kirkis; B Sweeney; O Sartawi; P Durrance; M Fell
Journal:  J Neurol       Date:  1995-06       Impact factor: 4.849

Review 6.  Can antiglycolipid antibodies present in HIV-infected individuals induce immune demyelination?

Authors:  S Petratos; M E Gonzales
Journal:  Neuropathology       Date:  2000-12       Impact factor: 1.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.